At a recent symposium hosted by the global aesthetics company Galderma on March 15, Dr. Joongsoo Kim, Chief Representative of Dayone Clinic, delivered a compelling lecture to an audience of over 500 medical professionals.
[Image by Day one Clinic]
The presentation, titled "What Are the Differences: Restylane® Skinboosters™ Vital Light vs. Others," addressed the evolving trends in the skinbooster market and the clinical advantages of Restylane® Vital Light in meeting modern patient demands.
Dr. Kim analyzed that the skinbooster market is shifting from a focus on general "regeneration" (such as collagen stimulation) toward more immediate and visible improvements in skin quality, including Glow, Texture, and Hydration. He noted that patients now prioritize treatments with minimal downtime and pain that deliver long-lasting, natural-looking radiance.
A key highlight of the lecture was the comparative analysis between Restylane® Vital Light and PN-based skinboosters, which are widely used in the Korean market. Dr. Kim pointed out that while PN products are known for their anti-inflammatory properties, they often involve significant injection pain and shorter-lasting effects.
In contrast, Restylane® Vital Light utilizes NASHA™ (Non-Animal Stabilized Hyaluronic Acid) technology. This creates a stabilized HA gel that stays in the skin longer—up to 15 months—to normalize and enhance the Extracellular Matrix (ECM) immediately, providing superior hydration with significantly less pain.
Dr. Kim emphasized the technical precision offered by the SmartClick™ system combined with a 34G nano-needle. "This combination allows for the precise delivery of HA into the junction between the dermis and subdermis," explained Dr. Kim. "By ensuring the exact dosage per click, we can minimize side effects like swelling and bruising while maximizing the 'glowing' effect that patients desire."
Concluding his session, Dr. Kim presented clinical data showing that Restylane® Vital Light’s effects can last up to 15 months (465 days) following a recommended treatment cycle. This longevity sets it apart as a highly efficient option in a market saturated with short-acting alternatives.
"The goal of modern aesthetic treatment is to provide immediate satisfaction with minimal disruption to daily life," said Dr. Kim. "Restylane® Vital Light remains a gold standard for achieving that subtle, natural radiance and structural hydration that today’s patients demand."
The symposium served as a vital platform for sharing advanced injection techniques and clinical insights, reinforcing Restylane®’s position as a leader in the global skinbooster market.